当前位置:首页 - 行情中心 - 沃华医药(002107) - 财务分析 - 现金流量表

沃华医药

(002107)

  

流通市值:37.48亿  总市值:37.98亿
流通股本:5.70亿   总股本:5.77亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金689,523,102.51464,617,345.83234,098,257.98863,664,672.25
  收到其他与经营活动有关的现金9,035,349.325,809,630.241,764,007.486,004,500.28
  经营活动现金流入小计698,558,451.83470,426,976.07235,862,265.46869,669,172.53
  购买商品、接受劳务支付的现金104,260,984.1268,986,792.732,066,818.82141,869,808.42
  支付给职工以及为职工支付的现金123,980,413.7484,635,690.6245,065,188.91173,157,656.17
  支付的各项税费80,789,964.4555,146,634.9926,871,865.3599,579,309.86
  支付其他与经营活动有关的现金280,825,836.68186,366,426.0183,691,728.17363,552,646.77
  经营活动现金流出小计589,857,198.99395,135,544.32187,695,601.25778,159,421.22
  经营活动产生的现金流量净额108,701,252.8475,291,431.7548,166,664.2191,509,751.31
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额14,650,27214,650,27214,650,00034,424
  处置子公司及其他营业单位收到的现金净额820,000820,000--
  收到的其他与投资活动有关的现金---189,435.39
  投资活动现金流入小计15,470,27215,470,27214,650,000223,859.39
  购建固定资产、无形资产和其他长期资产支付的现金546,677.53447,942.5358,7503,823,215.3
  投资活动现金流出小计546,677.53447,942.5358,7503,823,215.3
  投资活动产生的现金流量净额14,923,594.4715,022,329.4714,591,250-3,599,355.91
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金73,185,1523,920,0003,920,000144,302,400
  其中:子公司支付给少数股东的股利、利润3,920,0003,920,0003,920,000-
  支付其他与筹资活动有关的现金802,679.4519,985.83-347,801.74
  筹资活动现金流出小计73,987,831.44,439,985.833,920,000144,650,201.74
  筹资活动产生的现金流量净额-73,987,831.4-4,439,985.83-3,920,000-144,650,201.74
五、现金及现金等价物净增加额49,637,015.9185,873,775.3958,837,914.21-56,739,806.34
  加:期初现金及现金等价物余额342,876,205.9342,876,205.9342,876,205.9399,616,012.24
  期末现金及现金等价物余额392,513,221.81428,749,981.29401,714,120.11342,876,205.9
补充资料:
  净利润-41,177,664.22-33,758,540.88
  资产减值准备-1,545,569.11-1,305,451.05
  固定资产和投资性房地产折旧-14,649,977.89-30,513,010.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,649,977.89-30,513,010.94
  无形资产摊销-697,544.13-1,421,650.2
  固定资产报废损失-43,277.14-33,227.16
  财务费用-36,330.2-15,953.21
  投资损失--820,176.99--
  递延所得税-421,730.96--716,514.94
  其中:递延所得税资产减少-657,056.9--306,238.96
    递延所得税负债增加--235,325.94--410,275.98
  存货的减少-4,289,633.59-40,646,894.86
  经营性应收项目的减少--2,144,298.11-28,140,007.6
  经营性应付项目的增加-19,016,219.89--46,003,348.41
  现金的期末余额-428,749,981.29-342,876,205.9
  减:现金的期初余额-342,876,205.9-399,616,012.24
  现金及现金等价物的净增加额-85,873,775.39--56,739,806.34
公告日期2025-10-182025-07-222025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑